Research Article

Laboratory Investigation (2004) 84, 1322–1338, advance online publication, 2 August 2004; doi:10.1038/labinvest.3700161

AL-amyloidosis and light-chain deposition disease light chains induce divergent phenotypic transformations of human mesangial cells

John Keeling1,2,3, Jiamin Teng1 and Guillermo A Herrera1,2,3,4

  1. 1Department of Pathology, Louisiana State University Health Sciences, Shreveport, LA, USA
  2. 2Department of Cellular Biology, Louisiana State University Health Sciences, Shreveport, LA, USA
  3. 3Department of Anatomy, Louisiana State University Health Sciences, Shreveport, LA, USA
  4. 4Department of Medicine, Louisiana State University Health Sciences, Shreveport, LA, USA

Correspondence: Dr GA Herrera, MD, Department of Pathology, Louisiana State University Health Sciences, 1501 Kings Highway, Shreveport, LA 71130, USA. E-mail: gherre@lsuhsc.edu

Received 12 December 2003; Revised 16 June 2004; Accepted 22 June 2004; Published online 2 August 2004.

Top

Abstract

Human mesangial cells (HMCs) are injured by either excessive amounts or abnormal light chains (LCs), or a combination of both in patients with plasma cell dyscrasias. Consequently, these HMCs undergo phenotypic transformations. HMCs were incubated with eight different light-chains (LCs) for 96 h. These cells, in addition to 51 patient samples from patients with AL-amyloidosis (AL-Am), light-chain deposition disease (LCDD), myeloma cast nephropathy (MCN) and controls were analyzed by immunohistochemistry for CD68, muscle-specific actin (MSA), smooth muscle actin (SMA), CD14, and Ham56 protein expressions. All samples were also studied using electron microscopy. Greater staining (four- and three-fold) expressions of CD68 and Ham56, respectively, were observed in the HMCs incubated with AL-Am-LCs compared to those with LCDD-LCs and control. SMA expression levels were five-fold higher in LCDD-LC-treated cells compared to the other categories of LC-treated and control cells. Similar results were obtained in the renal specimens, however, CD68 levels were 12-fold higher in the AL-Am cases compared to the LCDD cases, respectively. Conversely, MSA and SMA levels were three fold higher in the LCDD cases than in the AL-Am ones. No CD14 expression was noted in any of the samples and CD-34 staining of HMCs treated with the various LCs only showed rare positive cells. Dynamic real-time studies to visualize the rough endoplasmic reticulum (RER) and lysosomal compartments in HMCs incubated with LCDD and AL-Am-LCs showed striking expansion of each of the above-mentioned compartments, respectively. This indicates the presence of more RER in the LCDD-LC-treated HMCs and a striking increase in lysosomes noticeable in the AL-Am-LC-treated cells. Data obtained in this study highlighted that HMCs incubated with LCDD-LCs undergo a myofibroblastic phenotypic transformation, while AL-Am-LCs induce a macrophage-like phenotype in these cells.

Keywords:

myeloma, light chains, CD68, MSA, SMA, mesangium, ultrastructure, immunohistochemistry

Extra navigation

.

naturejobs

ADVERTISEMENT